ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

Acute Retinal Pigment Epithelium Tear Four Days Post Intravitreal Aflibercept Injection: A Case Report |Biomedgrid

Journal: American Journal of Biomedical Science & Research (Vol.17, No. 4)

Publication Date:

Authors : ; ;

Page : 460-462

Keywords : Retinal pigment epithelium tear; Retinal pigment epithelium rip; Age-related macular degeneration; Anti-vascular endothelial growth factor; Aflibercept; Case report;

Source : Downloadexternal Find it from : Google Scholarexternal


Retinal Pigment Epithelium (RPE) tear is an uncommon but recognized complication of anti-Vascular Endothelial Growth Factor (anti-VEGF) treatment for neovascular age-related macular degeneration. This has predominantly been reported in association with bevacizumab (Avastin), ranibizumab (Lucentis), and pegaptanib (Macugen). Herein, we report a unique case of early RPE tear four days following an intravitreal aflibercept (Eylea) injection. To the best of our knowledge, this describes the earliest RPE tear following intravitreal aflibercept injection.

Last modified: 2024-07-10 21:54:05